WILLIAM KELLOGG
Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology BRUNSWICK, GA NPI 1265490643
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology GA Acerta Pharma LLC All categories
General Payments — all program years on this page
$23,911.36
- Category: General Payments
- Program years: PY2018–2024
- Record count: 1,201
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,085.96 across 50 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,085.96 | 50 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $137.25 | 7 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $96.37 | 4 |
| PFIZER INC. | $86.34 | 4 |
| Astellas Pharma US Inc | $54.31 | 2 |
| Genmab U.S., Inc. | $48.98 | 2 |
| JAZZ PHARMACEUTICALS INC. | $43.31 | 2 |
| Incyte Corporation | $42.96 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $42.93 | 2 |
| ABBVIE INC. | $42.34 | 2 |
| ASD SPECIALTY HEALTHCARE, LLC | $42.21 | 1 |
| Lilly USA, LLC | $40.52 | 2 |
| GlaxoSmithKline, LLC. | $39.51 | 2 |
| Merck Sharp & Dohme Corporation | $31.42 | 1 |
| E.R. Squibb & Sons, L.L.C. | $30.45 | 2 |
| PharmaEssentia USA Corporation | $29.78 | 1 |
| Regeneron Healthcare Solutions, Inc. | $25.74 | 1 |
| TerSera Therapeutics LLC | $24.63 | 1 |
| BeiGene USA, Inc. | $24.63 | 1 |
| Genentech USA, Inc. | $23.37 | 1 |
| Mirati Therapeutics, Inc. | $22.93 | 1 |
| Pharmacosmos Therapeutics Inc. | $19.81 | 1 |
| ADC Therapeutics America, Inc. | $18.31 | 1 |
| Celgene Corporation | $18.17 | 1 |
| Alexion Pharmaceuticals, Inc. | $18.09 | 1 |
| Gilead Sciences, Inc. | $18.01 | 1 |
| Exelixis Inc. | $17.35 | 1 |
| Kite Pharma, Inc. | $15.56 | 1 |
| PUMA BIOTECHNOLOGY, INC. | $15.40 | 1 |
| Ipsen Biopharmaceuticals, Inc | $15.28 | 1 |
By program year
Records — PY2024 (50)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.